Incyte Corp (NASDAQ:INCY)

88.68
Delayed Data
As of 4:00pm ET
 -0.65 / -0.73%
Today’s Change
62.48
Today|||52-Week Range
110.37
+1.56%
Year-to-Date

Today’s Trading

Previous close89.33
Today’s open92.36
Day’s range87.82 - 89.75
Volume15,987
Average volume (3 months)1,242,957
Market cap$19.8B
Data as of 4:00pm ET, 10/21/2020

Growth & Valuation

Earnings growth (last year)+299.90%
Earnings growth (this year)-143.33%
Earnings growth (next 5 years)+31.98%
Revenue growth (last year)+14.71%
P/E ratioNM
Price/Sales8.80
Price/Book7.54

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-4.93-3.49%
HZNPHorizon Therapeutics...-0.13-0.17%
CTLTCatalent Inc-0.55-0.59%
ALXNAlexion Pharmaceutic...-5.86-4.72%
Data as of 4:00pm ET, 10/21/2020

Financials

Next reporting dateNovember 3, 2020
EPS forecast (this quarter)$0.52
Annual revenue (last year)$2.2B
Annual profit (last year)$446.9M
Net profit margin20.70%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Wilmington, Delaware

Forecasts